Featured
-
Read More: Incomplete Adherence
Incomplete Adherence
-
Read More: Multiple DAA Treatment Failures (All Genotypes), Including Sofosbuvir/Velpatasvir/Voxilaprevir or Sofosbuvir Plus Glecaprevir/Pibrentasvir
Multiple DAA Treatment Failures (All Genotypes), Including Sofosbuvir/Velpatasvir/Voxilaprevir or Sofosbuvir Plus Glecaprevir/Pibrentasvir
Find a Resource
Search & Filter
Topic
Genotypes
Cirrhosis Status
Methods
Resource Type
-
Incomplete Adherence
There are minimal data regarding the outcome of patients who have incomplete adherence to DAA therapy or the threshold level…
-
Multiple DAA Treatment Failures (All Genotypes), Including Sofosbuvir/Velpatasvir/Voxilaprevir or Sofosbuvir Plus Glecaprevir/Pibrentasvir
Recommended regimens listed by evidence level and alphabetically for: Sofosbuvir/Velpatasvir/Voxilaprevir Treatment Failures, With or Without Compensated Cirrhosisa RECOMMENDED DURATION RATING Daily…
-
Glecaprevir/Pibrentasvir Treatment Failures
Recommended regimens listed by evidence level and alphabetically for: Glecaprevir/Pibrentasvir Treatment Failures (All Genotypes), With or Without Compensated Cirrhosisa RECOMMENDED DURATION…
-
Sofosbuvir-Based and Elbasvir/Grazoprevir Treatment Failures
In general, persons who have experienced treatment failure with a sofosbuvir-based regimen should be retreated with 12 weeks of sofosbuvir/velpatasvir/voxilaprevir.…
-
Treatment of HCV-Uninfected Transplant Recipients Receiving Organs From HCV-Viremic Donors
With the large disparity between patients in need of organ transplantation and available donor organs, many transplant programs are turning…
-
Simplified HCV Treatment Algorithm for Treatment-Naive Adults With Compensated Cirrhosis
Who Is NOT Eligible for Simplified Treatment (With Cirrhosis) Patients who have any of the following characteristics: Current or prior…
-
Simplified HCV Treatment* for Treatment-Naive Adults Without Cirrhosis
Who Is NOT Eligible for Simplified Treatment (Without Cirrhosis) Patients who have any of the following characteristics: Prior hepatitis C…
-
Sofosbuvir/Velpatasvir/Voxilaprevir Treatment Failure (All Genotypes)
Page Retired 1/21/2021 Recommended regimens listed by evidence level and alphabetically for: Patients With Prior Sofosbuvir/Velpatasvir/Voxilaprevir Treatment Failure (All Genotypes),…
-
Glecaprevir/Pibrentasvir Treatment Failure (All Genotypes)
Page Retired 1/21/2021 Recommended regimens listed by evidence level and alphabetically for: Patients With Prior Glecaprevir/Pibrentasvir Treatment Failure (All Genotypes),…
-
Management of Key Populations With Chronic HCV Infection
People who inject drugs (PWID), men who have sex with men (MSM), and individuals in jails and prisons bear a…
